Pages

▼
Sunday, August 18, 2024

Combo of Rituximab and Abatacept Starts a Phase-II In Honeymooners (T1D RELAY)

›
Rituximab is FDA-approved to treat several autoimmune diseases, including Rheumatoid Arthritis (RA).  About 10 years ago there were a coupl...
1 comment:
Tuesday, July 16, 2024

Abrocitinib and Ritlecitinib Start A Phase-IIΔ Clinical Trail in Honeymooners (JAKPOT)

›
(Note: JAKPOT is a name of at least two different clinical trials.  If you are reading about a French clinical trial targeting Rheumatoid Ar...
Tuesday, June 4, 2024

BMF-219 Starts a Phase-IIΔ

›
BMF-219 is a drug that inhibits  Menin , a protein.  Menin's functions in cells are not fully understood, and may be complex and contrad...
Wednesday, May 1, 2024

Fenofibrate Starts A Phase-IIΔ Trial

›
Fenofibrate (also spelled Phenofibrate) is commonly prescribed for high cholesterol and high triglycerides. In 2017, it was the 70th most ...
Friday, April 26, 2024

Siplizumab Starts Two Trials in Honeymoon T1D (DESIGNATE and STRIDE)

›
Siplizumab (MEDI-507, TCD601) is an monoclonal antibody which targets CD2 cells in the immune system.  It is being developed by ITB-MED ....
Friday, April 12, 2024

Why I Don't Blog On How To Vote For T1D (part 1)

›
This whole blog posting is very US (and US politics) focused, but the issues are similar in other countries.  Also, this blog is trying to d...
Friday, March 22, 2024

Diamyd Update Part 2: JDRF Flexibilty In Funding and Diamyd In More People

›
My previous blog posting: https://cureresearch4type1diabetes.blogspot.com/2023/12/diamyd-update.html described the main line of DIAGNODE cl...
1 comment: